Measuring vaccine efficacy from epidemics of acute infectious agents.

A good measure of field vaccine efficacy should evaluate the direct protective effect of vaccination on the person who receives the vaccine. The conventional estimator for vaccine efficacy depends on population level factors that are either unrelated or indirectly related to the direct biological action of the vaccine on persons, including population structure, duration of the study, the fraction vaccinated, and herd immunity, that is, indirect effects. Indirect effects can cause the conventional vaccine efficacy estimator to be inaccurate. We review alternative vaccine efficacy estimators that control for indirect effects at the population level. Thus, they are more accurate than the conventional estimator. We use epidemic simulations to explore the robustness of the conventional and proposed estimators under different field conditions. In addition, we apply the different vaccine efficacy estimators to data from a measles epidemic in Muyinga, Burundi.

[1]  M E Halloran,et al.  Study designs for dependent happenings. , 1991, Epidemiology.

[2]  A R Hinman,et al.  Assessing vaccine efficacy in the field. Further observations. , 1988, Epidemiologic reviews.

[3]  M E Halloran,et al.  The behaviour of common measures of association used to assess a vaccination programme under complex disease transmission patterns--a computer simulation study of malaria vaccines. , 1990, International journal of epidemiology.

[4]  M. Schechter,et al.  The role of secondary vaccine failures in measles outbreaks. , 1989, American journal of public health.

[5]  I M Longini,et al.  Models for the statistical analysis of infectious disease data. , 1988, Biometrics.

[6]  I. Longini,et al.  A generalized stochastic model for the analysis of infectious disease final size data. , 1991, Biometrics.

[7]  M E Halloran,et al.  Direct and indirect effects in vaccine efficacy and effectiveness. , 1991, American journal of epidemiology.

[8]  I. Longini,et al.  Household and community transmission parameters from final distributions of infections in households. , 1982, Biometrics.

[9]  J. T. Kemper,et al.  Error sources in the evaluation of secondary attack rates. , 1980, American journal of epidemiology.

[10]  M E Halloran,et al.  Modeling malaria vaccines. II: Population effects of stage-specific malaria vaccines dependent on natural boosting. , 1989, Mathematical biosciences.

[11]  R. May,et al.  Directly transmitted infections diseases: control by vaccination. , 1982, Science.

[12]  R. O’Neill,et al.  On sample sizes to estimate the protective efficacy of a vaccine. , 1988, Statistics in medicine.

[13]  M E Halloran,et al.  Interpretation and estimation of vaccine efficacy under heterogeneity. , 1992, American journal of epidemiology.

[14]  M. Halloran,et al.  Measures of the effects of vaccination in a randomly mixing population. , 1991, International journal of epidemiology.

[15]  I M Longini,et al.  Simulation studies of influenza epidemics: assessment of parameter estimation and sensitivity. , 1984, International journal of epidemiology.

[16]  I M Longini,et al.  A discrete-time model for the statistical analysis of infectious disease incidence data. , 1992, Biometrics.

[17]  I M Longini,et al.  Estimating household and community transmission parameters for influenza. , 1982, American journal of epidemiology.

[18]  P. Fine,et al.  Reflections on the efficacy of pertussis vaccines. , 1987, Reviews of infectious diseases.

[19]  G W Comstock,et al.  Vaccine evaluation by case-control or prospective studies. , 1990, American journal of epidemiology.

[20]  Robert T. Chen,et al.  Measles antibody: reevaluation of protective titers. , 1990, The Journal of infectious diseases.

[21]  B T Grenfell,et al.  Oscillatory fluctuations in the incidence of infectious disease and the impact of vaccination: time series analysis , 1984, Journal of Hygiene.

[22]  R. Anderson,et al.  Measles in developing countries. Part II. The predicted impact of mass vaccination , 1988, Epidemiology and Infection.

[23]  P G Smith,et al.  Assessment of the protective efficacy of vaccines against common diseases using case-control and cohort studies. , 1984, International journal of epidemiology.

[24]  H. P. Hudson,et al.  An application of the theory of probabilities to the study of a priori pathometry.—Part I , 1917 .

[25]  H. P. Hudson,et al.  An Application of the Theory of Probabilities to the Study of a Priori Pathometry.--Part III , 1917 .

[26]  Estimation of vaccine efficacy in outbreaks of acute infectious diseases. , 1991, Statistics in medicine.

[27]  P E Fine,et al.  The efficacy of pertussis vaccines under conditions of household exposure. Further analysis of the 1978-80 PHLS/ERL study in 21 area health authorities in England. , 1988, International journal of epidemiology.

[28]  S. Greenland,et al.  On measures and models for the effectiveness of vaccines and vaccination programmes. , 1988, International journal of epidemiology.

[29]  Greenwood,et al.  The Statistics of Anti-Typhoid and Anti-Cholera Inoculations, and the Interpretation of Such Statistics in General , 1915, Proceedings of the Royal Society of Medicine.

[30]  Ả. Svensson.  Analyzing effects of vaccines. , 1991, Mathematical biosciences.

[31]  I M Longini,et al.  Statistical inference for infectious diseases. Risk-specific household and community transmission parameters. , 1988, American journal of epidemiology.